Innovative drug discovery information platform 'Design Hub'

Following last year, we will hold the "Chemaxon User Group Meeting 2023" again this year on September 12 and September 15. This year, we plan to hold the event not only in Tokyo but also in Osaka. At this meeting, Japanese users who are actually utilizing Chemaxon products will share their use cases, which will help attendees better understand the appeal of Chemaxon products. As in previous years, there will also be a networking event where you can casually exchange information with fellow industry members and Chemaxon developers, so we kindly ask you to invite your colleagues and attend. For more details, please check our website via the details and registration button. Please note that this event requires prior registration, so we encourage you to register early.

The "Chemaxon User Group Meeting 2022" will be held on October 18 (Tuesday) as follows. In this meeting, we plan to introduce Chemaxon's new vision from the new CEO Richard Jones, provide an overview of the latest roadmap from the product development manager, and present case studies of the DesignHUB (compound design platform) used at Boehringer Ingelheim. There will also be a networking event where you can casually exchange information with fellow industry members and Chemaxon developers, so we kindly ask you to invite your colleagues and join us. For more details, please check our website via the details and registration button. This meeting requires prior registration, so please register early.

Chemical.AI, a global leader in artificial intelligence (AI) for synthetic route design and prediction, and Chemaxon, a leading company in chemical and biological software development, have announced a strategic partnership that will allow access to Chemical.AI's reverse synthesis tool, ChemAIRS, as an option from Chemaxon's drug discovery platform, Design Hub. This collaboration creates compatibility between Chemical.AI's ChemAIRS and Chemaxon's Design Hub, enabling a seamless user workflow and one-stop service that integrates compound design tracking and prioritization features from Design Hub with ChemAIRS's diverse strategies for innovative synthetic routes completed in minutes. For more details, please visit our website.

Chemaxon, a leader in the development of cheminformatics software for life sciences research, has announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard succeeds the owner, Ferenc (Csizi) Csizmadia, in this role. Csizi will continue to serve as a founder while focusing on the establishment of Ancestralize, which is centered on health and wellness in the digital age. Additionally, coinciding with Mr. Richard's appointment, Chemaxon's Budapest office has relocated to the newly constructed environmentally friendly office park, Váci Greens, on the east side of the Danube River. A new logo and spelling have also been announced. For more details, please visit the news article on our company's homepage via the link below.